No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
EKSO Ekso Bionics Holdings, Inc.
- 1.070
- +0.040+3.88%
Close Jul 5 16:00 ET
- 1.020
- -0.050-4.67%
Post 18:46 ET
19.45MMarket Cap-1103P/E (TTM)
1.070High1.020Low34.02KVolume1.020Open1.030Pre Close35.89KTurnover0.20%Turnover RatioLossP/E (Static)18.17MShares3.12952wk High1.38P/B18.60MFloat Cap0.62052wk Low--Dividend TTM17.38MShs Float863.099Historical High--Div YieldTTM4.85%Amplitude0.620Historical Low1.054Avg Price1Lot Size
Post-Market
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Ekso Bionics' (EKSO) New Partnership to Aid Its Ekso Devices
Lake Street Maintains Ekso Bionics Holdings, Inc.(EKSO.US) With Buy Rating, Maintains Target Price $2.5
Lake Street analyst Ben Haynor maintains $Ekso Bionics Holdings, Inc.(EKSO.US)$ with a buy rating, and maintains the target price at $2.5.According to TipRanks data, the analyst has a success rate of
Express News | Ekso Bionics Holdings Inc- Partnership to Incorporate Eksonr and Ekso Indego Devices Across Its Rehabilitation and Community Network
Express News | Ekso Bionics Announces Research Partnership With Shepherd Center
Ekso Bionics Holdings Initiated at Buy by Lake Street
Ekso Bionics Holdings Initiated at Buy by Lake Street
Lake Street Initiates Ekso Bionics Holdings, Inc.(EKSO.US) With Buy Rating, Announces Target Price $2.5
Lake Street analyst Ben Haynor initiates coverage on $Ekso Bionics Holdings, Inc.(EKSO.US)$ with a buy rating, and sets the target price at $2.5.According to TipRanks data, the analyst has a success r
Comments
Record Annual Revenue of $18.3 Million for Ekso Bionics: A Deep Dive into the Company's Success.
Ekso Bionics Holdings, Inc. ($EKSO), a leading developer of exoskeleton solutions that amplify human potential, has recently reported a record annual revenue of $18.3 million. This remarkable achievement highlights the company's successful business strategies and its ongoing commitment to innovation in the realm of robotic exoskeleton...
Ekso Bionics Holdings, Inc. ($EKSO), a leading developer of exoskeleton solutions that amplify human potential, has recently reported a record annual revenue of $18.3 million. This remarkable achievement highlights the company's successful business strategies and its ongoing commitment to innovation in the realm of robotic exoskeleton...
$Ekso Bionics Holdings, Inc.(EKSO.US$ $ReWalk Robotics(RWLK.US$ EKSO had some financing at 1.55 is not a bad. On other hand, that means revenue from medicare probably won’t be enough to make company profitable in short term.
Be careful.
Be careful.
$Ekso Bionics Holdings, Inc.(EKSO.US$Moomoo 24/7· 2 mins ago
Ekso Bionics Entered Into A Securities Purchase Agreement With Certain Institutional Investors For 2.9M Shares At $1.55/Share, With Gross Proceeds Of Approximately $4.6M![]()
Ekso Bionics Entered Into A Securities Purchase Agreement With Certain Institutional Investors For 2.9M Shares At $1.55/Share, With Gross Proceeds Of Approximately $4.6M
2
Ekso Bionics considers the CMS approval to positively impact SCI patients' health outcomes by increasing affordability of Ekso Indego Personal. This decision is expected to expand the patient population, potentially boosting product sales.
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg